Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: guarantee (67), certify (28), warrant (16)

How to care for your perineum after the birth of your baby - patient information

Description: This factsheet explains how to care for your perineum (also called the perineal area) after the birth of your baby.
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/How-to-care-for-your-perineum-after-the-birth-of-your-baby-831-PIL.pdf

MPF12 HaemOnc request form v10

Description: UHS LAB USE Specimen(s) received (central): BMT / Slides / BMA EDTA / PB EDTA / Cyto / other Specimen(s) distribution: Histo MGG Flow Flow WGLS Sal. Iron
Url: /Media/UHS-website-2019/Docs/Health-professionals/Pathology/MPF12-HaemOnc-request-form.docx

Understanding what is involved in a post mortem review of care-3119-PIL

Description: Information for bereaved parents on understanding what is involved in a postmortem and detailed review of care
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Understanding-what-is-involved-in-a-post-mortem-review-of-care-3119-PIL.pdf

Call for expressions of interest in ARC Deputy Director role

Description: Enc C NIHR ARC Wessex Deputy Director: Call for Expressions of Interest The University of Southampton NHS Foundation Trust (UHS) and
Url: /Media/Southampton-Clinical-Research/Downloads/Call-for-expressions-of-interest-in-ARC-Deputy-Director-role.pdf

Carboplatin-Pembrolizumab-Pemetrexed

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CARBOPLATIN (AUC 5)-PEMBROLIZUMAB-PEMETREXED Regimen • NSCLC – Carboplatin
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Carboplatin-Pembrolizumab-Pemetrexed.pdf

PV-CHP Cyclophosphamide-doxorubicin-polatuzumab vedotin -prednisolone

Description: Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-DOXORUBICIN-POLATUZUMAB VEDOTIN-PREDNISOLONE- RITUXIMAB Regimen • Lymphoma – Cyclophosphamide-doxor
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/PV-CHP-Cyclophosphamide-doxorubicin-polatuzumab-vedotin-prednisolone.pdf

Catheter-lab-day-unit - patient information

Description: Catheter (Cath) Lab Day Unit
Url: /Media/UHS-website-2019/Patientinformation/Heartandlungs/Catheter-lab-day-unit-2034-PIL.pdf

Cisplatin-Pembrolizumab-Pemetrexed

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CISPLATIN-PEMBROLIZUMAB-PEMETREXED Regimen • NSCLC – Cisp
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Cisplatin-Pembrolizumab-Pemetrexed.pdf

Cisplatin, Vinorelbine and radiotherapy

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CISPLATIN - VINORELBINE (RADIOTHERAPY) Regimen NSCLC – Cisplatin - Vinorelbine (Radiothera
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CisplatinVinorelbineandradiotherapyver12.pdf

Cisplatin and Vinorelbine (intravenous-adjuvant)

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CISPLATIN-VINORELBINE (Intravenous - Adjuvant) Regimen NSCLC – Cisplatin-Vinorelbine (Intr
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CisplatinandVinorelbineintravenous-adjuvantver12.pdf

481 to 490 of 1000

Previous … 47 48 49 50 51 … Next